Information Journal Paper
APA:
CopyMEIYANTO, EDY, Husnaa, Ulfatul, Kastian, Ria Fajarwati, Putri, Herwandhani, Larasati, Yonika Arum, Khumaira, Annisa, Putri Pamungkas, Dyaningtyas Dewi, JENIE, RIRIS ISTIGHFARI, Lestari, Beni, Yokoyama, Takashi, & Kato, Jun Ya. (2021). The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells. ADVANCED PHARMACEUTICAL BULLETIN, 11(1), 188-196. SID. https://sid.ir/paper/774484/en
Vancouver:
CopyMEIYANTO EDY, Husnaa Ulfatul, Kastian Ria Fajarwati, Putri Herwandhani, Larasati Yonika Arum, Khumaira Annisa, Putri Pamungkas Dyaningtyas Dewi, JENIE RIRIS ISTIGHFARI, Lestari Beni, Yokoyama Takashi, Kato Jun Ya. The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells. ADVANCED PHARMACEUTICAL BULLETIN[Internet]. 2021;11(1):188-196. Available from: https://sid.ir/paper/774484/en
IEEE:
CopyEDY MEIYANTO, Ulfatul Husnaa, Ria Fajarwati Kastian, Herwandhani Putri, Yonika Arum Larasati, Annisa Khumaira, Dyaningtyas Dewi Putri Pamungkas, RIRIS ISTIGHFARI JENIE, Beni Lestari, Takashi Yokoyama, and Jun Ya Kato, “The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells,” ADVANCED PHARMACEUTICAL BULLETIN, vol. 11, no. 1, pp. 188–196, 2021, [Online]. Available: https://sid.ir/paper/774484/en